Elenco degli articoli con argomento «tofacitinib»
Dermatologia17 nov 2019
Tofacitinib in Pediatric Psoriasis: An Open-Label Trial to Study Its Safety and Efficacy in Children
Psoriasis is a chronic, multifactorial, inflammatory disorder, with an estimated prevalence of 0.71% in children.
30 nov 2017
No Increase in Thromboembolic Events With Tofacitinib Treatment for Multiple Conditions
Investigators have found no evidence of an increased risk of venous thromboembolic events (VTE) in patients treated with tofacitinib for rheumatoid arthritis (RA), psoriasis (PsO), psoriatic arthritis (PsA), or ulcerative colitis (UC)
02 ott 2017
Tofacitinib Improves Plaque-Psoriasis Symptoms in Psoriatic Arthritis
Patients with active psoriatic arthritis and plaque psoriasis showed resolution of skin lesions within 3 weeks, as indicated by achieving Psoriasis Area and Severity Index (PASI 75) and PASI 90 with tofacitinib
06 feb 2017
Ema. Artrite reumatoide, psoriasi e non solo. A gennaio raccomandati per l'approvazione 8 nuovi farmaci
Pubblicato il report della riunione mensile del Comitato per i medicinali ad uso umano dell'Agenzia del farmaco europea. Tra gli otto nuovi prodotti raccomandati per l'immissione in commercio anche due biosimilari e due farmaci generici.
21 nov 2016
Tofacitinib a Potential Treatment for Active, Treatment-Unresponsive Psoriatic Arthritis
Tofacitinib demonstrated superior efficacy versus placebo in the treatment of active psoriatic arthritis (PsA) that has previously not responded well to treatment.
25 lug 2015
Tofacitinib Shows Promise for Patients With Refractory, Severe Eczema
Researchers have successfully treated patients with moderate to severe eczema using a rheumatoid arthritis drug recently shown to reverse 2 other disfiguring skin conditions: vitiligo and alopecia areata